Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients [NA]
Clinical trial evaluating endoscopic ultrasound-guided portal vein sampling for circulating tumor cells in pancreatic cancer patients has co…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: HCW9218 for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update reporting completion of a Phase 1/Phase 2 study of HCW9218 in advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating carbon ion radiation therapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer [Phase 2]
Phase 2 PaTcH trial of trametinib plus hydroxychloroquine in metastatic pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers [Phase 1]
Phase Ib trial evaluating adagrasib (KRAS G12C inhibitor) in combination with olaparib in KRAS G12C-mutated advanced solid tumors, focusing …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
ESPERANZA is an external control arm study of trastuzumab deruxtecan (T-DXd) for patients with HER2 IHC3+ solid tumors, sponsored by AstraZe…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of LEE011 (ribociclib) and everolimus in patients with metastatic pancreatic adenocarc…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]
This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressin…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating an IDO pathway inhibitor in combination with gemcitabine and nab-paclitaxel for metastatic pancreatic cancer; t…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: 9-ING-41 in Patients With Advanced Cancers [Phase 2]
Actuate Therapeutics' Phase 2 trial of 9-ING-41 in patients with advanced cancers is currently active but not recruiting, with pancreatic ca…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound [NA]
A completed clinical trial from Peking Union Medical College Hospital evaluated vinegar-induced collection of duodenal pancreatic juice duri…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies [Phase 1]
A Phase 1 clinical trial is evaluating the safety and tolerability of AB680 in participants with gastrointestinal malignancies, including ad…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer [NA]
This document reports the completion of a clinical trial evaluating early supportive care and nutritional support in adults with pancreatic …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: New Technique of Pancreaticojejunostomy During Whipple Operation [NA]
Theodor Bilharz Research Institute completed a clinical trial evaluating a new pancreaticojejunostomy technique used during the Whipple proc…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer [Phase 2]
Phase II trial updating the combination of vemurafenib and sorafenib in pancreatic cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) [Phase 2]
Phase 2 trial evaluating neoadjuvant mFOLFIRINOX with or without preoperative chemoradiotherapy in borderline resectable pancreatic cancer h…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) [NA]
Results for the PanECT study evaluating electrochemotherapy on the posterior resection surface to reduce recurrence in pancreatic cancer hav…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Splenic Artery Infusion Chemotherapy vs Systemic Chemotherapy in Advanced Pancreatic Body/Tail Cancer
This completed clinical trial compared splenic artery infusion chemotherapy with standard systemic chemotherapy in patients with unresectabl…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Niraparib in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial of niraparib in pancreatic cancer has completed; the snippet does not include study results.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial is evaluating a KRAS-specific autologous TCR-T cell therapy for KRAS-mutant advanced solid tumors, including colore…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy in combination with a focal adhesion kinase (FAK) inhibitor for advanced pancreatic …
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating oxaliplatin with irinotecan liposome injection II followed by 5-FU/leucovorin or Tegorgor oral therapy for…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial of EUS-guided intra-tumour injection of OncoSil for locally advanced pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer [Phase 1]
Phase 1 trial of NBTXR3 activated by radiation therapy for borderline resectable or locally advanced pancreatic cancer has been suspended.